157 related articles for article (PubMed ID: 37882750)
21. Engineering neoantigen vaccines to improve cancer personalized immunotherapy.
Liu Z; Lv J; Dang Q; Liu L; Weng S; Wang L; Zhou Z; Kong Y; Li H; Han Y; Han X
Int J Biol Sci; 2022; 18(15):5607-5623. PubMed ID: 36263174
[TBL] [Abstract][Full Text] [Related]
22. Neoantigen prediction from genomic and transcriptomic data.
Battaglia S
Methods Enzymol; 2020; 635():267-281. PubMed ID: 32122550
[TBL] [Abstract][Full Text] [Related]
23. ProTECT-Prediction of T-Cell Epitopes for Cancer Therapy.
Rao AA; Madejska AA; Pfeil J; Paten B; Salama SR; Haussler D
Front Immunol; 2020; 11():483296. PubMed ID: 33244314
[TBL] [Abstract][Full Text] [Related]
24. pVACtools: A Computational Toolkit to Identify and Visualize Cancer Neoantigens.
Hundal J; Kiwala S; McMichael J; Miller CA; Xia H; Wollam AT; Liu CJ; Zhao S; Feng YY; Graubert AP; Wollam AZ; Neichin J; Neveau M; Walker J; Gillanders WE; Mardis ER; Griffith OL; Griffith M
Cancer Immunol Res; 2020 Mar; 8(3):409-420. PubMed ID: 31907209
[TBL] [Abstract][Full Text] [Related]
25. Sources of Cancer Neoantigens beyond Single-Nucleotide Variants.
Capietto AH; Hoshyar R; Delamarre L
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077528
[TBL] [Abstract][Full Text] [Related]
26. ProGeo-Neo v2.0: A One-Stop Software for Neoantigen Prediction and Filtering Based on the Proteogenomics Strategy.
Liu C; Zhang Y; Jian X; Tan X; Lu M; Ouyang J; Liu Z; Li Y; Xu L; Chen L; Lin Y; Xie L
Genes (Basel); 2022 Apr; 13(5):. PubMed ID: 35627168
[TBL] [Abstract][Full Text] [Related]
27. Gene fusion neoantigens: Emerging targets for cancer immunotherapy.
Wang Y; Shi T; Song X; Liu B; Wei J
Cancer Lett; 2021 May; 506():45-54. PubMed ID: 33675984
[TBL] [Abstract][Full Text] [Related]
28. TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification.
Tang Y; Wang Y; Wang J; Li M; Peng L; Wei G; Zhang Y; Li J; Gao Z
BMC Bioinformatics; 2020 Nov; 21(1):532. PubMed ID: 33208106
[TBL] [Abstract][Full Text] [Related]
29. NeoFox: annotating neoantigen candidates with neoantigen features.
Lang F; Riesgo-Ferreiro P; Löwer M; Sahin U; Schrörs B
Bioinformatics; 2021 Nov; 37(22):4246-4247. PubMed ID: 33970219
[TBL] [Abstract][Full Text] [Related]
30. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
[TBL] [Abstract][Full Text] [Related]
31. Bioinformatic methods for cancer neoantigen prediction.
Boegel S; Castle JC; Kodysh J; O'Donnell T; Rubinsteyn A
Prog Mol Biol Transl Sci; 2019; 164():25-60. PubMed ID: 31383407
[TBL] [Abstract][Full Text] [Related]
32. A proteogenomic approach to target neoantigens in solid tumors.
Verma A; Halder A; Marathe S; Purwar R; Srivastava S
Expert Rev Proteomics; 2020; 17(11-12):797-812. PubMed ID: 33491499
[TBL] [Abstract][Full Text] [Related]
33. Splicing neoantigen discovery with SNAF reveals shared targets for cancer immunotherapy.
Li G; Mahajan S; Ma S; Jeffery ED; Zhang X; Bhattacharjee A; Venkatasubramanian M; Weirauch MT; Miraldi ER; Grimes HL; Sheynkman GM; Tilburgs T; Salomonis N
Sci Transl Med; 2024 Jan; 16(730):eade2886. PubMed ID: 38232136
[TBL] [Abstract][Full Text] [Related]
34. Accounting for proximal variants improves neoantigen prediction.
Hundal J; Kiwala S; Feng YY; Liu CJ; Govindan R; Chapman WC; Uppaluri R; Swamidass SJ; Griffith OL; Mardis ER; Griffith M
Nat Genet; 2019 Jan; 51(1):175-179. PubMed ID: 30510237
[TBL] [Abstract][Full Text] [Related]
35. HLA class-I and class-II restricted neoantigen loads predict overall survival in breast cancer.
Ren Y; Cherukuri Y; Wickland DP; Sarangi V; Tian S; Carter JM; Mansfield AS; Block MS; Sherman ME; Knutson KL; Lin Y; Asmann YW
Oncoimmunology; 2020; 9(1):1744947. PubMed ID: 32523802
[TBL] [Abstract][Full Text] [Related]
36. TSNAD and TSNAdb: The Useful Toolkit for Clinical Application of Tumor-Specific Neoantigens.
Wu J; Zhou Z
Methods Mol Biol; 2023; 2673():167-174. PubMed ID: 37258913
[TBL] [Abstract][Full Text] [Related]
37. TSNAdb v2.0: The Updated Version of Tumor-specific Neoantigen Database.
Wu J; Chen W; Zhou Y; Chi Y; Hua X; Wu J; Gu X; Chen S; Zhou Z
Genomics Proteomics Bioinformatics; 2023 Apr; 21(2):259-266. PubMed ID: 36209954
[TBL] [Abstract][Full Text] [Related]
38. Advances in personalized neoantigen vaccines for cancer immunotherapy.
Sun C; Xu S
Biosci Trends; 2020 Nov; 14(5):349-353. PubMed ID: 32908077
[TBL] [Abstract][Full Text] [Related]
39. TIminer: NGS data mining pipeline for cancer immunology and immunotherapy.
Tappeiner E; Finotello F; Charoentong P; Mayer C; Rieder D; Trajanoski Z
Bioinformatics; 2017 Oct; 33(19):3140-3141. PubMed ID: 28633385
[TBL] [Abstract][Full Text] [Related]
40. Neoantigens in precision cancer immunotherapy: from identification to clinical applications.
Zhang Q; Jia Q; Zhang J; Zhu B
Chin Med J (Engl); 2022 Jun; 135(11):1285-1298. PubMed ID: 35838545
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
